A2W Pharma, located in Malta, was created in 2019 by Amino Chemicals, a pharmaceutical company also based in Malta with over 30 years of experience in the field of active pharmaceutical substance research and development.
A2W is focused on harnessing the medicinal powers within the cannabis plant and is focused on creating prescription grade products that will provide better treatment options for patients where traditional therapies fall short. The company has extraction capabilities using super critical CO2 technology and also has state of the art automated filling, bottling and labelling equipment in house.
Additionally, A2W strives to be at the forefront of process development, analytical development and pre-formulation testing, and has over 250 square meters of QC & R&D lab space dedicated to generating the most advanced, optimised and cost-effective techniques for obtaining, isolating and processing active substances and related molecules.
Added By Mike Morgan-Giles
